GPRC5D (Talquetamab Biosimilar) Recombinant Monoclonal Antibody
-
貨號:CSB-RA882153MB1HU
-
規(guī)格:¥83486
-
其他:
產(chǎn)品詳情
-
產(chǎn)品描述:GPRC5D(Talquetamab Biosimilar Antibody)重組單克隆抗體是針對G蛋白偶聯(lián)受體C家族5成員D(G-protein coupled receptor family C group 5 member D,簡稱GPRC5D)開發(fā)。GPRC5D作為一種跨膜蛋白,在多發(fā)性骨髓瘤等惡性漿細胞疾病中呈現(xiàn)高表達特性,成為近年來血液腫瘤治療領(lǐng)域的重要分子靶點。該抗體以重組人GPRC5D蛋白制備,具有高度靶向性,種屬反應(yīng)性限定為人類,確保了其在人體研究中的特異性結(jié)合與生物學(xué)活性。 Talquetamab展現(xiàn)出顯著的治療潛力。其作用機制與藥物發(fā)現(xiàn)的陽性對照一致,通過特異性識別并結(jié)合腫瘤細胞表面的GPRC5D,觸發(fā)抗體依賴的細胞介導(dǎo)的細胞毒性(ADCC)和補體依賴的細胞毒性(CDC)等免疫效應(yīng),直接誘導(dǎo)腫瘤細胞凋亡。多項早期臨床試驗數(shù)據(jù)顯示,該抗體研發(fā)的藥物在復(fù)發(fā)/難治性多發(fā)性骨髓瘤患者中可產(chǎn)生深度且持久的緩解,尤其對既往接受過多種治療方案(包括CD38單抗、BCMA靶向藥物)無效的患者具有突破性療效。目前,相關(guān)研究正聚焦于優(yōu)化給藥方案、聯(lián)合用藥策略(如與免疫調(diào)節(jié)劑或化療藥物聯(lián)用)以進一步提升療效并降低不良反應(yīng)風(fēng)險。 GPRC5D重組單克隆抗體為腫瘤生物學(xué)機制研究提供了關(guān)鍵工具。其高度特異性使其可用于GPRC5D在正常組織與腫瘤組織中的表達譜分析,助力闡明該受體在腫瘤發(fā)生、發(fā)展及耐藥中的作用。此外,在藥物開發(fā)領(lǐng)域,該抗體可作為陽性對照用于新型GPRC5D靶向藥物(如雙特異性抗體、抗體偶聯(lián)藥物)的篩選與活性評價。研究人員還可通過免疫沉淀技術(shù),利用該抗體深入探索GPRC5D介導(dǎo)的信號通路,為開發(fā)更精準(zhǔn)的治療策略奠定基礎(chǔ)。隨著對GPRC5D生物學(xué)功能的深入解析,該抗體在腫瘤免疫治療機制研究及轉(zhuǎn)化醫(yī)學(xué)領(lǐng)域的應(yīng)用價值將持續(xù)擴大。
-
Uniprot No.:
-
基因名:
-
別名:GPRC5D; G-protein coupled receptor family C group 5 member D
-
反應(yīng)種屬:Human
-
免疫原:Recombinant Human GPRC5D protein
-
免疫原種屬:Homo sapiens (Human)
-
標(biāo)記方式:Non-conjugated
-
克隆類型:Monoclonal
-
濃度:It differs from different batches. Please contact us to confirm it.
-
保存緩沖液:0.01M PBS,pH7.4
-
產(chǎn)品提供形式:Liquid
-
應(yīng)用說明:Validation Status
Application-specific performance (e.g., in flow cytometry, ELISA, IHC or other assay formats) has not yet been experimentally verified by CUSABIO. Users are advised to determine the optimal working conditions empirically in their own assay systems.
Guaranteed Quality
① Antibody purity?> 95% tested by SDS-PAGE.
② Endotoxin level < 0.1EU/ug tested by LAL method. -
儲存條件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期:In stock
-
用途:It is a non-therapeutic biosimilar antibody, owning the same variable region from the corresponding approved therapeutic antibody. In conclusion, it is a research-grade biosimilar antibody and expressed in mammalian cell, which can be directly used as positive controls in drug discovery or used for rapid verification of the biological functions of target protein.
相關(guān)產(chǎn)品
靶點詳情
-
基因功能參考文獻:
- GPRC5D in MM cells makes this gene and its encoded surface protein as promising markers for monitoring the tumor load and hopefully also as targets for antimyeloma antibodies. PMID: 23510526
- Overexpression of G protein-coupled receptor 5D in the bone marrow is associated with poor prognosis in patients with multiple myeloma. PMID: 22591013
-
亞細胞定位:Cell membrane; Multi-pass membrane protein.
-
蛋白家族:G-protein coupled receptor 3 family
-
組織特異性:Widely expressed in the peripheral system. Expression pattern is high in pancreas, medium in kidney, small intestine, spleen and testis, low in lung, colon, leukocyte, prostate and thymus and not detectable in brain, heart, liver, placenta, skeletal muscl
-
數(shù)據(jù)庫鏈接:
Most popular with customers
-
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-















